▶ 調査レポート

遺伝子組換え蛋白医薬品の中国市場2017

• 英文タイトル:China Recombinant Protein Drugs Market Research Report 2017

QYResearchが調査・発行した産業分析レポートです。遺伝子組換え蛋白医薬品の中国市場2017 / China Recombinant Protein Drugs Market Research Report 2017 / A042113177資料のイメージです。• レポートコード:A042113177
• 出版社/出版日:QYResearch / 2017年3月8日
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥342,400 (USD3,200)▷ お問い合わせ
  Enterprise¥684,800 (USD6,400)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、遺伝子組換え蛋白医薬品の中国市場について調査・分析し、遺伝子組換え蛋白医薬品の中国市場概観、遺伝子組換え蛋白医薬品の種類別市場分析、用途別市場分析、遺伝子組換え蛋白医薬品の中国市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、中国市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・遺伝子組換え蛋白医薬品の中国市場概観
・遺伝子組換え蛋白医薬品の種類別市場規模
・遺伝子組換え蛋白医薬品の用途別市場規模
・遺伝子組換え蛋白医薬品の中国市場規模
・遺伝子組換え蛋白医薬品の中国市場予測
・遺伝子組換え蛋白医薬品の製造メーカー分析
・遺伝子組換え蛋白医薬品のメーカー別生産量
・遺伝子組換え蛋白医薬品のメーカー別市場シェア
・遺伝子組換え蛋白医薬品の価格動向・価格分析
・遺伝子組換え蛋白医薬品の販売(売上高)動向
・遺伝子組換え蛋白医薬品の貿易(輸出・輸入)動向
・遺伝子組換え蛋白医薬品の産業チェーン分析
・遺伝子組換え蛋白医薬品のマーケティング戦略分析
・遺伝子組換え蛋白医薬品の販売業者(代理店)リスト
・遺伝子組換え蛋白医薬品の市場環境分析
...

Notes:Sales, means the sales volume of Recombinant Protein Drugs
Revenue, means the sales value of Recombinant Protein Drugs

This report studies Recombinant Protein Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Recombinant Protein Drugs in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

China Recombinant Protein Drugs Market Research Report 2017
1 Recombinant Protein Drugs Market Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Recombinant Protein Drugs Segment by Type
1.2.1 China Production Market Share of Recombinant Protein Drugs Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Recombinant Protein Drugs
1.3.1 Recombinant Protein Drugs Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Recombinant Protein Drugs (2012-2022)
1.5 China Recombinant Protein Drugs Status and Outlook
1.6 Government Policies

2 China Recombinant Protein Drugs Market Competition by Manufacturers
2.1 China Recombinant Protein Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Recombinant Protein Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Recombinant Protein Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Protein Drugs Market Competitive Situation and Trends
2.5.1 Recombinant Protein Drugs Market Concentration Rate
2.5.2 Recombinant Protein Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Recombinant Protein Drugs Manufacturers Profiles/Analysis
3.1 Novo Nordisk
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Recombinant Protein Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Novo Nordisk Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Amgen
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Recombinant Protein Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Amgen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Sanofi
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Recombinant Protein Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Sanofi Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Eli Lilly
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Recombinant Protein Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Eli Lilly Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Merck Serono
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Recombinant Protein Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Merck Serono Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Ortho Biotech
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Recombinant Protein Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Ortho Biotech Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Roche
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Recombinant Protein Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Roche Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Kyowa Hakko Kirin
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Recombinant Protein Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Pharmingen
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Recombinant Protein Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Pharmingen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Abcam
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Recombinant Protein Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Abcam Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 GenSci
3.12 SL PHARM
3.13 Dongbao Pharm
3.14 Ankebio
3.15 NCPC
3.16 Heng Rui

4 China Recombinant Protein Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Recombinant Protein Drugs Capacity, Production and Growth (2012-2017)
4.2 China Recombinant Protein Drugs Revenue and Growth (2012-2017)
4.3 China Recombinant Protein Drugs Production, Consumption, Export and Import (2012-2017)

5 China Recombinant Protein Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Recombinant Protein Drugs Production and Market Share by Type (2012-2017)
5.2 China Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Recombinant Protein Drugs Price by Type (2012-2017)
5.4 China Recombinant Protein Drugs Production Growth by Type (2012-2017)

6 China Recombinant Protein Drugs Market Analysis by Application
6.1 China Recombinant Protein Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaRecombinant Protein Drugs Market Analysis by Regions (Provinces)
7.1 China Recombinant Protein Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Recombinant Protein Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Recombinant Protein Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Recombinant Protein Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Recombinant Protein Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Recombinant Protein Drugs Production, Consumption, Export and Import (2012-2017)

8 Recombinant Protein Drugs Manufacturing Cost Analysis
8.1 Recombinant Protein Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant Protein Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Recombinant Protein Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Recombinant Protein Drugs Market Forecast (2017-2022)
12.1 China Recombinant Protein Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Recombinant Protein Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Recombinant Protein Drugs Production Forecast by Type (2017-2022)
12.4 China Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)
12.5 China Recombinant Protein Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Recombinant Protein Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Recombinant Protein Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Recombinant Protein Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Recombinant Protein Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Recombinant Protein Drugs
Figure China Production Market Share of Recombinant Protein Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Recombinant Protein Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Recombinant Protein Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Recombinant Protein Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Recombinant Protein Drugs Capacity of Key Manufacturers in 2015
Figure China Recombinant Protein Drugs Capacity of Key Manufacturers in 2016
Table China Recombinant Protein Drugs Production of Key Manufacturers (2015 and 2016)
Table China Recombinant Protein Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Drugs Production Share by Manufacturers
Figure 2016 Recombinant Protein Drugs Production Share by Manufacturers
Table China Recombinant Protein Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Recombinant Protein Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2016 China Recombinant Protein Drugs Revenue Share by Manufacturers
Table China Market Recombinant Protein Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Recombinant Protein Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant Protein Drugs Product Type
Figure Recombinant Protein Drugs Market Share of Top 3 Manufacturers
Figure Recombinant Protein Drugs Market Share of Top 5 Manufacturers
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Recombinant Protein Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Recombinant Protein Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Recombinant Protein Drugs Market Share (2012-2017)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono Recombinant Protein Drugs Market Share (2012-2017)
Table Ortho Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ortho Biotech Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Ortho Biotech Recombinant Protein Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Recombinant Protein Drugs Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Market Share (2012-2017)
Table Pharmingen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmingen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pharmingen Recombinant Protein Drugs Market Share (2012-2017)
Table Abcam Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abcam Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Abcam Recombinant Protein Drugs Market Share (2012-2017)
Table GenSci Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SL PHARM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongbao Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ankebio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NCPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heng Rui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Recombinant Protein Drugs Capacity, Production and Growth (2012-2017)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Recombinant Protein Drugs Production, Consumption, Export and Import (2012-2017)
Table China Recombinant Protein Drugs Production by Type (2012-2017)
Table China Recombinant Protein Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Recombinant Protein Drugs by Type
Table China Recombinant Protein Drugs Revenue by Type (2012-2017)
Table China Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Recombinant Protein Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant Protein Drugs by Type
Table China Recombinant Protein Drugs Price by Type (2012-2017)
Figure China Recombinant Protein Drugs Production Growth by Type (2012-2017)
Table China Recombinant Protein Drugs Consumption by Application (2012-2017)
Table China Recombinant Protein Drugs Consumption Market Share by Application (2012-2017)
Figure China Recombinant Protein Drugs Consumption Market Share by Application in 2015
Table China Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
Table China Recombinant Protein Drugs Production by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Recombinant Protein Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure China Recombinant Protein Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Recombinant Protein Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Recombinant Protein Drugs Production Forecast by Type (2017-2022)
Table China Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)
Table China Recombinant Protein Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Recombinant Protein Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Recombinant Protein Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)